Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion type Assertion NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_head.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion description "[Biochemical recurrence defined as a total PSA of >0.2 ng/ml on 2 consecutive tests was considered as the surrogate endpoint for survival analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_provenance.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion evidence source_evidence_literature NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_provenance.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion SIO_000772 21803613 NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_provenance.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion wasDerivedFrom befree-20140225 NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_provenance.
- NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_assertion wasGeneratedBy ECO_0000203 NP251819.RAXxpPjH6NOJfXqjsRJcMLR5YpKaRTnUwXkPnRM50OT3g130_provenance.